You have 9 free searches left this month | to do more

entinostat

Entinostat is a drug used to treat Breast Cancer, Recurrent Adult Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, and other conditions. Entinostat is being actively studied in 21 studies and prior, has been studied in 23.

Top SponsorsTop SitesTop Investigators
National Cancer Institute (NCI)Johns Hopkins University/Sidney Kimmel Cancer CenterRoberto Pili
Syndax PharmaceuticalsRoswell Park Cancer InstituteAntonio Fojo
Roberto PiliMemorial Sloan Kettering Cancer CenterJianqing Lin
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Recruiting
  • Neuroendocrine Tumors
  • Entinostat
  • New York, New York
    Columbia University Medical Center
2021-10-06
Oct 6, 2021
A
Withdrawn
  • Pancreas Cancer
  • Entinostat
  • FOLFOX regimen
  • (no location specified)
2021-01-13
Jan 13, 2021
S
Active, not recruiting
  • Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Cancer
  • +3 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
2021-08-18
Aug 18, 2021
U
Recruiting
  • Melanoma
  • Chapel Hill, North Carolina
    UNC Lineberger Comprehensive Cancer Center
2021-05-08
May 8, 2021
A
Completed
  • Colorectal Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2020-12-16
Dec 16, 2020
S
Completed
  • Lung Cancer
  • +3 more
  • entinostat
  • +2 more
  • Sarasota, Florida
  • +2 more
2021-11-11
Nov 11, 2021
G
Terminated
  • Prostate Adenocarcinoma
  • Washington, District of Columbia
    George Washington University - Medical Faculty Associates
2021-07-26
Jul 26, 2021
R
Active, not recruiting
  • Renal Cell Carcinoma
  • Entinostat
  • +2 more
  • Washington, District of Columbia
  • +1 more
2021-07-26
Jul 26, 2021
N
Suspended
  • Cancer
  • +3 more
  • Bintrafusp Alfa
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-10-19
Oct 19, 2021
U
Terminated
  • Breast Cancer
  • +2 more
  • Entinostat
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
2021-03-22
Mar 22, 2021
R
Active, not recruiting
  • Metastatic Cancer
  • Renal Cancer
  • Indianapolis, Indiana
  • +3 more
2021-07-09
Jul 9, 2021
N
Not yet recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • Entinostat
  • (no location specified)
2021-11-05
Nov 5, 2021
T
Active, not recruiting
  • Advanced Breast Cancer
  • Entinostat
  • +2 more
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy Medical Sciences
2021-07-07
Jul 7, 2021
U
Recruiting
  • Metastatic Breast Cancer
  • Breast Cancer
  • Rochester, New York
  • +1 more
2020-09-11
Sep 11, 2020
M
Recruiting
  • Lymphoma
  • +2 more
  • Evanston, Illinois
  • +8 more
2021-07-08
Jul 8, 2021
V
Recruiting
  • Fallopian Tube Cancer
  • +12 more
  • Kansas City, Kansas
  • +1 more
2021-07-14
Jul 14, 2021
N
Active, not recruiting
  • Male Breast Carcinoma
  • +4 more
  • Duarte, California
  • +6 more
2021-06-12
Jun 12, 2021
R
Active, not recruiting
  • Renal Cell Carcinoma
  • Los Angeles, California
  • +4 more
2020-09-11
Sep 11, 2020
N
Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
2021-02-09
Feb 9, 2021
N
V
Active, not recruiting
  • Metastatic Uveal Melanoma
  • Gothenburg, Västra Götaland Region, Sweden
    Department of oncology, Sahlgrenska University Hospital
2019-10-15
Oct 15, 2019
U
Recruiting
  • Bladder Cancer
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
2021-02-18
Feb 18, 2021
S
Recruiting
  • Non-Small Cell Lung Cancer
  • Epigenetic Therapy
  • Los Angeles, California
  • +4 more
2021-06-03
Jun 3, 2021